Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rangering i aksjer #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Aksjekurs
$266.50
Markedsverdi
$642.24B
Endring (1 dag)
-1.13%
Endring (1 år)
50.92%
Land
US
Handel Johnson & Johnson (JNJ)

Kategori

Inntekter for Johnson & Johnson (JNJ)
Inntekter i Jun 2026 TTM: $25.20B
Ifølge Johnson & Johnson sine nyeste økonomiske rapporter er selskapets nåværende resultat $25.20B. I 2024 hadde selskapet et resultat på $16.69B, en økning sammenlignet med resultatet i 2023, som var $15.06B. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Johnson & Johnson fra 2000 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $25.20B -22.67%
2025 $32.58B 95.25%
2024 $16.69B 10.79%
2023 $15.06B -21.46%
2022 $19.18B 16.25%
2021 $16.50B -4.80%
2019 $17.33B -3.73%
2018 $18.00B 1.84%
2017 $17.67B -10.76%
2016 $19.80B 3.16%
2015 $19.20B -6.65%
2014 $20.56B 32.91%
2013 $15.47B 12.31%
2012 $13.78B 11.44%
2011 $12.36B -27.06%
2010 $16.95B 7.57%
2009 $15.76B -6.93%
2008 $16.93B 27.45%
2007 $13.28B -8.94%
2006 $14.59B 11.22%
2005 $13.12B 6.37%
2004 $12.33B 19.63%
2003 $10.31B 10.95%
2002 $9.29B 17.64%
2001 $7.90B 15.00%
2000 $6.87B 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$33.60B 33.34%
US
$8.70B -65.47%
US
$21.39B -15.11%
CH
$5.95B -76.39%
US
$16.38B -35.00%
CH